NHS Greater Glasgow & Clyde Area Drug and Therapeutics Committee
Greater Glasgow and Clyde Medicines
Greater Glasgow and Clyde Medicines
Posted: May 03, 2018.
Category - Medicines Update
There is currently a significant shortage of all intravenous immunoglobulins (IVIG). The National Plasma Product Expert Advisory Group (NPPEAG) has issued guidance to all NHS Boards regarding how to manage this situation.&...
Posted: May 03, 2018.
Category - Medicines Update
Important new drug safety information from the MHRA regarding
Posted: May 03, 2018.
Category - Medicines Update
Currently within NHSGGC acute sector we are using the new Inhixa® brand of enoxaparin 20 mg and 40 mg pre-filled syringes. Inhixa® is regarded as a “biosimilar” medicine to Clexane® and is considere...
Posted: May 03, 2018.
Category - Medicines Update
The following is a joint quote from David Murdoch, Chair of the Heart MCN and Christine McAlpine, Chair of the Stroke MCN in NHSGGC. “The Heart MCN supported by the Stroke MCN have updated the atrial fibrillation (AF)&nb...
Posted: May 02, 2018.
Category - Formulary Update
This post summarises the latest NHS Greater Glasgow and Clyde decisions relating to new medicines considered by the Area Drug and Therapeutics Committee (ADTC) and uses a nationally developed format specifically aimed for patients and the public.
For full details of the medicines included in this post that are available for use, including any restrictions on prescribing, please see the relevant entry in the GGC Formulary.
Posted: April 09, 2018.
Category - Medicines Update
The Therapeutics Handbook content has now been updated and includes the following main changes: Cardiovascular The
Posted: March 28, 2018.
Category - Medicines Update Extra
DOAC Prescribing in Patients with Non-Valvular AF and for the Treatment and Prevention of VTE** This bulletin supersedes MUE 05 **
The FAQ includes:
For information on the NHSGGC DOAC Patient Information Booklet and Alert Card click here.
Posted: March 12, 2018.
Category - Medicines Update
New Adult NHSGGC Guidelines now available on StaffNet
Posted: March 09, 2018.
Category - Medicines Update
If individuals opt for private healthcare treatment or assessment, they are still entitled to NHS services. The Central Prescribing Team are often asked by GPs what they should do if a patient requests a medicine following consultation with a p...
Posted: March 09, 2018.
Category - Medicines Update
Key messages Xaggitin® XL is now the preferred brand of methylphenidate prolonged-release tablets and should be prescribed across all care settings instead of Concer...